Type of security: Stock
Sector: Capital Goods
The data is delayed by 15 minutes.
BIO is in the long-term up 167% in 7 years.
Description: Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test sy
|Shares Outstanding||EPS||2.61||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-11.92%||Sales Growth - Q/Q||-20.96%||P/E||84.52|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||3.01%||ROE||4.55%||ROI||3.44%|
|Current Ratio||4.08||Quick Ratio||2.93||Long Term Debt/Equity||0.34||Debt Ratio||0.19|
|Gross Margin||54.87%||Operating Margin||7.66%||Net Profit Margin||4.68%||Dividend Payout Ratio|
|Cash From Financing Activities||-330 K||Cash From Investing Activities||-27.99 M||Cash From Operating Activities||29.45 M||Gross Profit||270.11 M|
|Net Profit||17.82 M||Operating Profit||34.35 M||Total Assets||3.33 B||Total Current Assets||1.7 B|
|Total Current Liabilities||416.88 M||Total Debt||435.93 M||Total Liabilities||1.13 B||Total Revenue||472.82 M|
|High 52 week||317.41||Low 52 week||233.97||Last close||296.72||Last change||-0.85%|
|RSI||48.26||Average true range||9.52||Beta||0.73||Volume||71.23 K|
|Simple moving average 20 days||-0.93%||Simple moving average 50 days||-2.38%||Simple moving average 200 days||5.89%|
|Performance Week||-4.62%||Performance Month||1.68%||Performance Quart||9.76%||Performance Half||2.09%|
|Performance Year||10.07%||Performance Year-to-date||-3.49%||Volatility daily||1.85%||Volatility weekly||4.13%|
|Volatility monthly||8.46%||Volatility yearly||29.32%||Relative Volume||236.57%||Average Volume||249.47 K|
|New High||0.51%||New Low|
2019-10-12 15:34:00 | Here’s What Hedge Funds Think About Bio-Rad Laboratories, Inc. BIO
2019-10-08 10:36:02 | LabCorp LH Names Two Leaders for Major Business Wings
2019-10-07 06:36:10 | Bruker To Buy Freiberg Instruments' Magnettech EPR Business
2019-10-02 09:48:01 | Abbott ABT Gets FDA Nod for New Troponin-I Blood Test
2019-09-18 09:07:09 | Goldman Sachs: 4 Conviction Buy Stocks To Snap Up Now
2019-09-12 17:28:48 | After record IPO, East Bay company's CEO targets growth — and sleep
2019-09-12 09:55:33 | On eve of biggest biotech IPO this year, 2 East Bay companies spar over patents
2019-09-11 17:48:00 | Bio-Rad Files New Lawsuit Against 10X Genomics for Patent Infringement
2019-08-31 09:31:01 | Bio-Rad BIO Up 8.8% Since Last Earnings Report: Can It Continue?
2019-08-29 18:13:45 | Biome Sees Revenue Quadruple, Gross Profits Triple In Q2
2019-08-29 15:20:07 | Edited Transcript of BIO earnings conference call or presentation 1-Aug-19 9:00pm GMT
2019-08-23 06:51:10 | Here's Why You Should Retain Bio-Rad BIO Stock for Now
2019-08-19 17:45:47 | How a biotech revolution catapulted this East Bay company to a $100M IPO
2019-08-09 09:30:01 | PRGO vs. BIO: Which Stock Is the Better Value Option?
2019-08-02 09:15:01 | Bio-Rad Bio Q2 Earnings Beat Estimates, Margins Expand
2019-08-01 20:26:34 | Bio-Rad Laboratories Inc BIO BIO-B Q2 2019 Earnings Call Transcript
2019-08-01 18:15:10 | Bio-Rad Laboratories BIO Surpasses Q2 Earnings and Revenue Estimates
2019-08-01 16:15:00 | Bio-Rad Reports Second-Quarter 2019 Financial Results
2019-07-30 12:20:38 | Do Insiders Own Shares In Biome Grow Inc. CNSX:BIO?
2019-07-23 20:46:00 | Bio-Rad to Report Second-Quarter 2019 Financial Results
2019-07-18 09:19:01 | IVD Market Sustains Momentum: 3 Stocks in Focus
2019-07-15 09:12:01 | ABT or BIO: Which Stock Has Better Potential Right Now?
2019-07-04 09:06:01 | Here's Why You Should Invest in CONMED CNMD Stock Now
2019-07-03 09:41:01 | Luminex LMNX Presents ARIES MRSA Assay to FDA for Clearance
2019-06-27 15:35:08 | Bio-Rad Laboratories, Inc. -- Moody's upgrades Bio-Rad to Baa2, outlook is stable
2019-06-14 08:29:11 | Here’s What Hedge Funds Think About Bio-Rad Laboratories, Inc. BIO
2019-06-14 06:53:06 | What Kind Of Shareholder Appears On The BIOTON S.A.'s WSE:BIO Shareholder Register?
2019-06-12 07:30:00 | 9 major Bay Area tech employers pay a typical worker more than $200K per year
2019-06-10 08:08:05 | See what the IHS Markit Score report has to say about Bio Rad Laboratories Inc.
2019-06-07 09:30:01 | Bio-Rad BIO Down 6.9% Since Last Earnings Report: Can It Rebound?
2019-06-03 14:03:00 | Bio-Rad to Participate in Goldman Sachs Annual Global Healthcare Conference on June 11
2019-05-31 08:09:12 | Here's Why You Should Retain Bio-Rad BIO Stock For Now
2019-05-24 12:00:32 | When Will Biome Grow Inc. CNSX:BIO Become Profitable?
2019-05-23 16:09:00 | Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4
2019-05-09 09:03:01 | Bio-Rad BIO Q1 Earnings Beat Estimates, Margins Expand
2019-05-08 21:36:50 | Edited Transcript of BIO earnings conference call or presentation 8-May-19 9:00pm GMT
2019-05-08 20:23:55 | Bio-Rad Laboratories Inc BIO Q1 2019 Earnings Call Transcript
2019-05-08 19:05:11 | Bio-Rad Laboratories BIO Q1 Earnings and Revenues Beat Estimates
2019-05-08 18:00:38 | Bio-Rad: 1Q Earnings Snapshot
2019-05-08 16:15:00 | Bio-Rad Reports First Quarter 2019 Financial Results
2019-05-07 10:38:02 | Will Life Sciences Sales Boost Bio-Rad's BIO Q1 Earnings?
2019-05-07 08:06:52 | See what the IHS Markit Score report has to say about Bio Rad Laboratories Inc.